Application of Sanguisorba officinalis saponin I in quality detection of holly leaf samples and corresponding quality detection methods

The content of saponin I in the Lycium Bone leaf samples was determined by liquid chromatography, which solved the problem of lack of quality detection methods for Lycium Bone leaf samples, and realized the whole process quality control of medicinal materials, decoctions, standard decoctions and formula granules. An efficient and economical testing solution.

CN116359355BActive Publication Date: 2024-11-12JIANGYIN TIANJIANG PHARMA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202111614013.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-12-27
Publication Date
2024-11-12
Estimated Expiration
2041-12-27

AI Technical Summary

Technical Problem

In the prior art, there is a lack of quality detection methods for Lycium bone leaf samples, and there is a lack of full-process control means, especially continuous quality control from medicinal materials to preparations is difficult to achieve.

Method used

Liquid chromatography combined with specific conditions (such as chromatographic column fillers, mobile phases, detectors, etc.) to determine the content of saponin I in the yogurt leaf samples, and establish a quality detection method for yogurt leaf samples, which is suitable for medicinal materials, decoctions, Quality detection of standard decoctions and formula granules.

Benefits of technology

It provides new analytical means for quality detection of wolfberry leaf samples, and realizes the quality control of the entire process of medicinal materials, decoctions, standard decoctions and formula granules. It is simple to operate, good reproducibility, low detection cost and high efficiency.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116359355B_ABST
    Figure CN116359355B_ABST
Patent Text Reader

Abstract

The present invention belongs to the technical field of drug analysis, and specifically relates to the application of sanguisorba officinalis saponin I in the quality detection of holly leaf samples and a corresponding quality detection method. The present invention provides a quality detection method for holly leaf samples, which comprises the following steps: preparation of a reference solution, preparation of a test solution, liquid chromatography detection and data analysis, wherein the data analysis comprises calculating the content of sanguisorba officinalis saponin I in the holly leaf sample. The present invention uses sanguisorba officinalis saponin I as an indicator component, provides a new analytical means for the quality detection of holly leaf samples, and has simple operation, good reproducibility and stability, reliable recovery rate, low detection cost and high detection efficiency.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of drug analysis, and particularly relates to application of sanguisorba officinalis saponin I in quality detection of holly leaf samples, and a method for performing quality detection on holly leaf samples by using sanguisorba officinalis saponin I. Background Art

[0002] Holly leaf is a traditional Chinese medicine, also known as cat's thorn, holly thorn, tiger thorn, star anise thorn, bird's nest, Kuding tea, etc. It was first recorded in "Compendium of Materia Medica" and has a long history of medicinal use. [1,2] The Chinese Pharmacopoeia (2020 edition) records that holly leaves are the dried leaves of the holly plant Ilex cornuta Lindl.ex Paxt. of the Aquifoliaceae family. Its functions and indications are to clear away heat, nourish yin, benefit the kidneys, and soothe the liver. It is used for hemoptysis caused by pulmonary tuberculosis, bone steaming, hot flashes, and dizziness. [3] In the Jiangsu and Zhejiang areas, its young leaves are used as Kuding tea, and the "National Compendium of Chinese Herbal Medicines" records that it has the effect of curing headaches and relieving fever. [4] Modern research shows that holly leaves mainly contain triterpenes, saponins, flavonoids and other components, which have immunosuppressive, anti-inflammatory, bactericidal, anti-fertility, and cardiovascular system protection activities. [5~9] .

[0003] Regarding the quality control of holly leaf medicinal materials, the "Chinese Pharmacopoeia" (2020 edition) does not include content determination items [3] The Hong Kong Chinese Herbal Medicine Standard uses ursolic acid and lupeol as content determination indicators.

[10] Guo Yajian, Li Yan and other scholars have established methods for determining the contents of ursolic acid and lupeol in holly leaves. [11,12] Hong Yanping, Cai Wei, Shi Zhiqi and Chen Ying established methods for determining the content of total flavonoids and polyphenolic compounds such as hyperoside, kaempferol and chlorogenic acid in holly leaves. [13~16] Wang Cunqin, Yao Zhirong and Zhou Guoli established a method for determining the content of long-pedunculated holly glycoside, holly glycoside II and total saponins in holly leaves. [17~19] Regarding the quality control of holly leaf preparations, only Nie Liyun and other scholars have established a method for determining the content of isorhamnetin-3-O-β-D-glucoside and formononetin in holly leaf extracts.

[20] The above methods only control the medicinal materials, or only control the extracts, and lack the control of the same indicator from the medicinal materials to the preparations.

[0004] There are currently few patent applications for quality control of holly leaves. In particular, there are no patent applications for the determination of the content of holly leaf medicinal materials and decoction pieces. There is currently only one patent for the determination of the content of holly leaf preparations, namely, "Holy Leaf Formula Granules and Their Preparation Methods and Detection Methods" applied by Sun Dongmei et al.

[21] The patent uses infrared fingerprint spectrum to detect the quality of holly leaf slices and formula granules, and uses hydrolysis method to determine fingerprint spectrum in raw medicinal material control to control the quality of holly leaf. However, the hydrolysis method determines the hydrolysis product, which cannot reflect the original components in the raw medicinal material, and the infrared spectroscopy method cannot reflect the content of a specific component.

[0005] As a kind of holly leaf preparation, holly leaf formula granules are made under the guidance of traditional Chinese medicine theory, using holly leaf pieces that meet the standards of the current edition of the "Chinese Pharmacopoeia", and are extracted, separated, concentrated, dried, and granulated by water heating. After being prepared according to the clinical prescription of traditional Chinese medicine, it is used by patients. Holly leaf formula granules have basically the same therapeutic effects and pharmacological effects as traditional water decoctions, and also have the advantages of small size, easy to carry and store. Due to the use of water extraction, the water solubility of triterpenoid components with low polarity such as ursolic acid and lupeol is poor, so they are not suitable for the quality control of holly leaf formula granules; although components such as hyperoside, kaempferol and organic acids have a certain degree of water solubility, they are distributed in many plants and have poor specificity.

[0006] Ziyuglycoside I (1-O-[(3β)-3-(α-L-Arabinopyranosyloxy)-19-hydroxy-28-oxours-12-en-28-yl]-β-D-glucopyranose) is an ursane-type pentacyclic triterpenoid saponin with the molecular formula: C 41 H 66 O 13 , CAS No.: 35286-58-9, its structural formula is as follows:

[0007]

[0008] It has been reported in many literatures that holly leaves contain sanguisorba officinalis saponin I [1,2,5 ~9], but the method for its content determination has not been disclosed, nor has sanguisorbaenoside I been used as a means of quality control.

[0009] References:

[0010] [1] Chinese Materia Medica Dictionary (Second Edition) Editorial Committee. Chinese Materia Medica Dictionary (Second Edition)[M]. Shanghai: Shanghai Science and Technology Press, 2005: 784.

[0011] [2] Chinese Materia Medica Editorial Committee. Chinese Materia Medica (Volume 5)[M]. Shanghai: Shanghai Science and Technology Press, 1999: 147-148.

[0012] [3] Chinese Pharmacopoeia Committee. Pharmacopoeia of the People's Republic of China (2020 Edition) Volume 1[S]. Beijing: China Medical Science and Technology Press, 2010: 261.

[0013] [4] National Compilation of Chinese Herbal Medicines Editing Group. National Compilation of Chinese Herbal Medicines (Second Edition, Volume 1) [M]. Beijing: People's Medical Publishing House, 1996: 602-603.

[0014] [5] Yang Weihua, Zhao Yucong. Research progress on chemical components and pharmacological effects of Chinese herbal medicine holly leaves[J]. Medical World, 2007, 9(3):103.

[0015] [6] Peng Guoquan, Yang Dongmei. Medicinal and health-care effects of holly[J]. Journal of Jiangxi Agricultural Sciences, 2011, 23(6): 79-82.

[0016] [7] Zuo Wenjian, Mei Wenli, Zeng Yanbo, et al. Research progress on chemical composition and pharmacological activity of holly[J]. Anhui Agricultural Sciences, 2011, 39(27): 16560-16562.

[0017] [8] Wang Cunqin, He Dan. Research progress on chemical components and pharmacological activities of holly[J]. Journal of Baotou Medical College, 2016, 32(8): 160-162.

[0018] [9] Yi F, Zhao Xl, Peng Y, et al. Genus Ilex L. Phytochemistry, Ethnopharmacology, and Pharmacology [J]. Chinese Herbal Medicines, 2016, 8(3): 209-230.

[0019]

[10] Hong Kong Chinese Materia Medica Standards, Vol. 7, pp. 256-268. https: / / www.cmro.gov.hk / files / hkcmms / vol7 / main.html.

[0020]

[11] Guo Yajian, Cui Yuping, Zhou Jing, et al. Determination of ursolic acid content in holly leaves collected at different times [J]. China Journal of Traditional Chinese Medicine, 1995, 20(10): 591-592.

[0021]

[12] Li Yan, Wu Tao, Wang Zhengtao, et al. Determination of lupeol content in holly leaves by RP-HPLC[J]. Chinese Journal of Traditional Chinese Medicine, 2008, 33(2): 149-152.

[0022]

[13] Hong Yanping, Shangguan Xinchen, Liu Nan, et al. Extraction and determination of total flavonoids from holly leaves[J]. Journal of Jiangxi Agricultural University, 2008, 30(3): 529-533.

[0023]

[14] Cai Wei. Determination of hyperoside content in holly leaves by HPLC[J]. Northern Pharmacy, 2016, 13(1):1.

[0024]

[15] Shi Zhiqi, Wang Luolin, Xie Yuan, et al. Simultaneous determination of quercetin, kaempferol and isorhamnetin in holly leaves by HPLC[J]. Chinese Journal of Hospital Pharmacy, 2014, 34(21): 1831-1833.

[0025]

[16] Chen Ying, Wang Cunqin, Wang Lei, et al. Simultaneous determination of 10 polyphenols in holly leaves by HPLC[J]. New Chinese Medicines and Clinical Pharmacology, 2019, 30(6): 715-718.

[0026]

[17] Wang Cunqin, Wang Lei, Chen Ying, et al. Simultaneous determination of the contents of four triterpenoid components in holly leaves harvested at different times by HPLC[J]. Chinese Journal of New Drugs and Clinical Pharmacology, 2020, 31(9): 1092-1096.

[0027]

[18] Yao Zhirong, Li Jun, Zhao Mingbo, et al. Determination of holly glycoside II in holly leaves by HPLC-ELSD[J]. China Journal of Traditional Chinese Medicine, 2010, 35(17): 2312-2314.

[0028]

[19] Zhou Guoli, Shu Ke, Nie Lixiao, et al. Determination of total saponin content in Chinese medicinal materials holly leaves from different origins [J]. Journal of Hunan University of Traditional Chinese Medicine, 2010, 30(7): 33-35.

[0029]

[20] Nie Liyun, Cao Xu. Simultaneous determination of isorhamnetin-3-O-β-D-glucoside and formononetin in holly leaf extract by HPLC[J]. Pharmaceutical Research, 2017, 36(3): 142-144.

[0030]

[21] Sun Dongmei, Wang Luolin, Shi Zhiqi, et al. Holly leaf formula granules and their preparation method and detection method [P]. CN103800399B, 2016.08.17. Summary of the invention

[0031] Problem that the invention aims to solve

[0032] In view of the fact that there are relatively few substances used as quality evaluation indicators of holly leaf samples (such as crude drugs, decoction pieces, standard decoctions and preparations) in the field, and the corresponding lack of quality detection methods for holly leaf samples, in order to enrich the quality control methods of holly leaf, the present invention proposes to apply sanguisorbaenoside I to the quality detection of holly leaf samples, and establishes a method for determining the content of sanguisorbaenoside I in holly leaf samples, providing a new analytical means for controlling the intrinsic quality of holly leaf samples, and realizing the full process control of holly leaf medicinal materials, decoction pieces, standard decoctions and formula granules.

[0033] Solutions for solving problems

[0034] [1]. A method for quality testing of holly leaf samples, comprising the following steps: preparation of a reference solution, preparation of a test solution, liquid chromatography testing and data analysis, wherein the data analysis comprises calculating the content of sanguisorbaenoside I in the holly leaf sample.

[0035] [2] The quality inspection method according to [1] is characterized in that the holly leaf sample is selected from one or more of the medicinal materials, decoction pieces, extracts, standard decoctions and formula granules of holly leaves.

[0036] [3]. The quality inspection method according to [1] or [2] is characterized in that the conditions adopted for the liquid chromatography inspection include: the chromatographic column filler is octadecylsilane bonded silica gel; the mobile phase A is acetonitrile or methanol, preferably the mobile phase A is acetonitrile; the mobile phase B is formic acid aqueous solution, acetic acid aqueous solution, phosphoric acid aqueous solution or water, preferably the mobile phase B is formic acid aqueous solution with a concentration of 0.2% by volume of formic acid.

[0037] [4]. The quality detection method according to [3] is characterized in that the conditions used in the liquid chromatography detection also include: using the mobile phase A and the mobile phase B for isocratic elution or gradient elution, preferably isocratic elution, and more preferably the volume ratio of mobile phase A to mobile phase B is 15:85 to 50:50; the flow rate is 0.20-0.40mL / min; the column temperature is 20-45°C; and an ultraviolet detector, an evaporative light scattering detector, a differential refractometer detector or a charged aerosol detector is used.

[0038] [5]. The quality inspection method according to any one of [1] to [4] is characterized in that the preparation of the test solution comprises the following steps: taking holly leaf sample powder, accurately weighing it, placing it in a container, accurately adding the extraction solvent, sealing it, weighing it, cooling it after extraction, weighing it again, making up the lost weight with the extraction solvent, shaking it well, filtering it, taking half the volume of the filtrate, evaporating it to dryness, adding the extraction solvent to the residue to re-dissolve it, transferring it to a quantitative container, adding the extraction solvent to the fixed volume, shaking it well, filtering it, and taking the filtrate to obtain it.

[0039] [6]. The quality inspection method according to [5] is characterized in that the mass volume ratio of the holly leaf sample powder to the extraction solvent is 1g:(15-800mL).

[0040] [7] The quality inspection method according to [5] or [6] is characterized in that the extraction solvent is an alcohol or an alcohol aqueous solution; preferably, the extraction solvent is methanol or a methanol aqueous solution; more preferably, the concentration of the methanol aqueous solution is greater than or equal to 30% by volume of methanol.

[0041] [8] The quality inspection method according to any one of [5] to [7] is characterized in that the extraction is carried out by ultrasound, heating reflux or shaking, and the extraction time is 5-60 minutes.

[0042] [9]. The quality inspection method according to any one of [1] to [7] is characterized in that the preparation of the reference solution comprises the following steps: taking a reference substance of Sanguisorba officinalis saponin I, accurately weighing it, adding a solvent, and mixing until it is dissolved; wherein the solvent is an alcohol or an alcohol aqueous solution; preferably, the solvent is methanol or a methanol aqueous solution; more preferably, the concentration of the methanol aqueous solution is greater than or equal to 30% by volume of methanol.

[0043]

[10] . Use of Sanguisorba officinalis saponin I in quality testing of holly leaf samples. Preferably, the holly leaf samples are selected from one or more of holly leaf medicinal materials, decoction pieces, extracts, standard decoctions, formula granules, and classical prescriptions containing holly leaf material standards and finished granules.

[0044] Effects of the Invention

[0045] Through the implementation of the above technical scheme, the present invention establishes a method for determining the content of sanguisorbaenoside I in holly leaf samples through liquid chromatography and reasonable control of chromatographic conditions, which can provide a new analytical means for quality detection of holly leaf samples.

[0046] At the same time, the method of the present invention uses sanguisorba officinalis saponin I as an indicator component, and is not only suitable for the quality detection of holly leaf medicinal materials, decoction pieces, standard decoctions and formula granules, but also suitable for the detection of other products containing holly leaf.

[0047] In addition, the method of the present invention is simple to operate, has good reproducibility and stability, reliable recovery rate, low detection cost and high detection efficiency, so as to provide a basis for standardizing the market and reasonable development of holly leaf medicinal materials and preparations. BRIEF DESCRIPTION OF THE DRAWINGS

[0048] Figure 1 This is the ultra-high performance liquid chromatogram of the Sanguisorba officinalis saponin I reference substance.

[0049] Figure 2 This is the ultra-high performance liquid chromatogram of holly leaf medicinal materials extracted using different solvents.

[0050] Figure 3 This is the ultra-high performance liquid chromatogram of holly leaf medicinal materials extracted by different methods.

[0051] Figure 4 This is the ultra-high performance liquid chromatogram of holly leaf medicinal material extracted using different volumes of solvent.

[0052] Figure 5 This is the ultra-high performance liquid chromatogram of holly leaf medicinal materials extracted at different times.

[0053] Figure 6 This is a linear relationship diagram between the Ln value of the injection amount of Sanguisorba officinalis saponin I reference substance in ultra-high performance liquid chromatography and the Ln value of the peak area.

[0054] Figure 7 This is the ultra-high performance liquid chromatogram of the specificity experimental results for the determination of the medicinal content of holly leaves.

[0055] Figure 8 Ultra-high performance liquid chromatograms showing the results of investigation at different flow rates.

[0056] Fig. 9 Ultra-high performance liquid chromatograms showing the results of investigation at different column temperatures.

[0057] Fig.10 Ultra-high performance liquid chromatograms showing the results of investigation using different chromatographic columns.

[0058] Fig.11 This is the ultra-high performance liquid chromatogram of the specificity experimental results for the content determination of holly leaf slices.

[0059] Fig.12 This is the ultra-high performance liquid chromatogram of the specificity experimental results for content determination of standard decoction of holly leaves.

[0060] Fig.13 This is the ultra-high performance liquid chromatogram of the specificity experimental results for content determination of holly leaf formula granules. DETAILED DESCRIPTION

[0061] The following describes the embodiments of the present invention, but the present invention is not limited thereto. The present invention is not limited to the various structures described below, and various changes can be made within the scope of the invention claim, and the embodiments and examples obtained by appropriately combining the technical means disclosed in different embodiments and examples are also included in the technical scope of the present invention.

[0062] Unless defined otherwise, technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.

[0063] In the present invention, a numerical range expressed using “a numerical value A to a numerical value B” or “a numerical value A-a numerical value B” means a range including the endpoints A and B.

[0064] In the present invention, the meaning of "may" includes both the meaning of performing a certain process and the meaning of not performing a certain process. In this specification, "optional" or "optionally" means that the event or situation described below may or may not occur, and the description includes the situation where the event occurs and the situation where the event does not occur.

[0065] In the present invention, the term "a" or "an" or "the" may mean "one", and may also mean "one or more", "at least one" and "one or more than one".

[0066] In the present invention, the term "about" may mean that a value includes the standard deviation of the error of the device or method used to determine the value. The numerical ranges and parameters used to define the present invention are all approximate values, and the relevant values ​​in the specific embodiments have been presented as accurately as possible. However, any numerical value essentially inevitably contains standard deviations caused by the aforementioned test devices or methods. Therefore, unless otherwise expressly stated, it should be understood that all ranges, quantities, values ​​and percentages used in the present invention are modified by "about". Here, "about" generally means that the actual value is within ±10%, ±5%, ±1% or ±0.5% of a particular value or range.

[0067] In the present invention, the term "comprises" and any of their variations are intended to cover non-exclusive inclusions. For example, a process, method, system, product or device comprising a series of steps or units is not limited to the listed steps or units, but may optionally include steps or units that are not listed, or may optionally include other steps or units that are inherent to these processes, methods, products or devices.

[0068] In the present invention, "drug material" or "raw drug" refers to raw materials of traditional Chinese medicine that have not been processed or made into finished products.

[0069] In the present invention, "prepared pieces" refer to Chinese medicines that are processed according to needs and are used for prescription, or Chinese medicines that can be directly used in clinical Chinese medicine.

[0070] In the present invention, "extract" refers to an extract that meets certain quality standards and is produced according to a standardized production process, for example, an alcohol (such as methanol, ethanol, etc.) extract, a water extract, etc.

[0071] In the present invention, "standard decoction" refers to a single-flavor Chinese medicine decoction prepared by standardized process under the guidance of traditional Chinese medicine theory, based on clinical application, and with reference to modern extraction methods.

[0072] In the present invention, "formulated granules" are granules prepared from single-flavor Chinese herbal medicine pieces processed according to traditional standards and then extracted and concentrated for use in clinical prescriptions of traditional Chinese medicine.

[0073] In the present invention, "classic prescription material benchmark" refers to the Chinese medicinal substance prepared based on the preparation method of ancient classic prescriptions recorded in ancient medical books. Except for the molding process, the rest of the preparation method should be basically consistent with the records in ancient medical books.

[0074] In the present invention, "finished granules of classic prescriptions" or "standard granules of classic prescriptions" refer to granules prepared by extracting and concentrating ancient classic prescriptions recorded in ancient medical books for use in clinical prescriptions of traditional Chinese medicine.

[0075] In the present invention, "test sample" refers to an experimental sample used for detection or identification.

[0076] In the present invention, "reference substance" refers to a standard substance used for identification, inspection, content determination and calibration of instrument performance.

[0077] In the present invention, "liquid chromatograph" refers to a type of analysis and separation instrument that uses liquid as a mobile phase, which can be divided into high performance liquid chromatography (commonly referred to as HPLC) and ultra high performance liquid chromatography (commonly referred to as UPLC or UHPLC).

[0078] In this specification, the references to "some specific / preferred embodiments", "other specific / preferred implementations", "embodiments", "implementations", etc., mean that the specific elements (e.g., features, structures, properties and / or characteristics) related to the embodiments described are included in at least one embodiment described herein, and may or may not exist in other embodiments. In addition, it should be understood that the elements may be combined in various embodiments in any suitable manner.

[0079] [Holly leaf sample]

[0080] In some embodiments, the holly leaf sample of the present invention includes one or more of holly leaf medicinal materials, decoction pieces, extracts, standard decoctions, formula granules, and material references and finished granules of classic prescriptions containing holly leaf. In some specific embodiments, the holly leaf sample of the present invention includes one or more of holly leaf medicinal materials, decoction pieces, extracts, standard decoctions, and formula granules.

[0081] [Preparation of test solution]

[0082] In some specific embodiments, the preparation of the test solution of the present invention comprises the following steps: taking holly leaf sample powder, accurately weighing, placing in a container (e.g., a stoppered conical flask), accurately adding an extraction solvent, sealing, weighing, extracting (e.g., ultrasonicating, heating, or shaking), cooling, weighing again, making up the lost weight with the extraction solvent, shaking, filtering, taking half the volume of the filtrate, evaporating to dryness, adding the extraction solvent to the residue to re-dissolve, transferring to a quantitative container (e.g., a volumetric flask), adding the extraction solvent to the fixed volume, shaking, filtering, taking the filtrate, and obtaining.

[0083] In the present invention, the extraction solvent may be water, alcohols, such as methanol, ethanol, butanol or pentanol, etc., or an alcohol aqueous solution, such as methanol aqueous solution.

[0084] In some specific embodiments, in the preparation of the test solution of the present invention, the extraction solvent is an alcohol, such as methanol.

[0085] In some specific embodiments, in the preparation of the test solution of the present invention, the extraction solvent is an alcohol aqueous solution, such as a methanol aqueous solution; preferably, the concentration of the methanol aqueous solution is greater than or equal to 30% by volume of methanol. If the volume percentage of methanol is too low, it is not conducive to the extraction of components. Specifically, it can be 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 99%, etc.; in order to further improve the extraction efficiency, the concentration of the methanol aqueous solution is preferably 30%-70%, and even more preferably 50%-70%.

[0086] In some embodiments, in the preparation of the test solution of the present invention, the mass volume ratio of the holly leaf sample powder to the extraction solvent is 1g: (15-800mL); if the sample concentration is too small or too large, it may exceed the linear relationship range. In some specific embodiments, in the preparation of the test solution of the present invention, the mass volume ratio of the holly leaf sample powder to the extraction solvent is 1g: (40-200mL), which can be 1g: 40mL, 1g: 60mL, 1g: 80mL, 1g: 100mL, 1g: 120mL, 1g: 140mL, 1g: 160mL, 1g: 180mL or 1g: 200mL. In some more specific embodiments, in order to further optimize the extraction effect and material dosage, the mass volume ratio of the holly leaf sample powder to the methanol aqueous solution is 1g: (80-120mL), which can be 1g: 100mL.

[0087] In some specific embodiments, in the preparation of the test solution of the present invention, the extraction treatment can be carried out by ultrasound, heating reflux or shaking. In some embodiments, in the preparation of the test solution of the present invention, the extraction treatment time is 5 to 60 minutes, specifically 5 minutes, 10 minutes, 15 minutes, 20 minutes, 25 minutes, 30 minutes, 35 minutes, 40 minutes, 45 minutes, 50 minutes, 55 minutes or 60 minutes. In some specific embodiments, in the preparation of the test solution of the present invention, the extraction treatment time is 15 to 45 minutes. If the time is too short, it is not conducive to the full dissolution of the components, and if the time is too long, the efficiency of the analysis work is reduced. In order to make the extraction operation simple, it is preferred to use an ultrasonic treatment method, and the power and frequency of the ultrasound have little effect on the present invention. In some preferred embodiments, the power of the ultrasonic treatment is 250W and the frequency is 40kHz. In order to further optimize the extraction effect and the treatment cycle, it is preferred that the ultrasonic treatment time is 15 to 30 minutes, specifically 30 minutes.

[0088] In some preferred embodiments, the preparation of the test solution of the present invention comprises the following steps: taking holly leaf sample powder, accurately weighing it, placing it in a stoppered conical flask, accurately adding a methanol aqueous solution with a concentration of 30% to 70%, sealing it, weighing it, extracting it by ultrasonic or heating or shaking for 15-45 minutes, cooling it, weighing it again, making up the lost weight with the methanol aqueous solution, shaking it well, filtering it, taking half the volume of the filtrate, evaporating it to dryness, re-dissolving the residue with the methanol aqueous solution, transferring it to a volumetric flask, adding the methanol aqueous solution to make up the volume, shaking it well, filtering it, and taking the filtrate to obtain it; wherein, the mass volume ratio of the holly leaf sample powder to the methanol aqueous solution is 1g:(40-200mL).

[0089] [Preparation of reference solution]

[0090] In some specific embodiments, the preparation of the reference solution of the present invention comprises the following steps: taking a reference substance of Sanguisorba officinalis saponin I, accurately weighing it, adding a solvent, and mixing it until it is dissolved.

[0091] In some specific embodiments, in the preparation of the reference solution of the present invention, the solvent is an alcohol or an alcohol aqueous solution, such as methanol or a methanol aqueous solution; preferably, in order to simplify the practical steps, the solvent used to prepare the reference solution can be the same as the extraction solvent used to prepare the test solution, and the concentration of the methanol aqueous solution is greater than or equal to 30% by volume of methanol, specifically 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 100%; accordingly, the concentration of the methanol aqueous solution can also be preferably 30%-70%, and even more preferably 50%-70%.

[0092] In some specific embodiments, in the preparation of the reference solution of the present invention, the concentration of the Sanguisorba officinalis saponin I reference in the solvent is 50 μg / mL.

[0093] In some specific embodiments, the Sanguisorbaside I reference substance of the present invention is commercialized Sanguisorbaside I.

[0094] [Liquid chromatography detection]

[0095] In some specific embodiments, the quality detection method of the holly leaf sample of the present invention adopts liquid chromatography. In some preferred embodiments, the quality detection method of the holly leaf sample of the present invention adopts ultra-high performance liquid chromatography.

[0096] In some specific embodiments, the chromatographic column filler used in the liquid chromatography detection of the present invention is octadecylsilane bonded silica gel.

[0097] In some specific embodiments, the chromatographic column used in the liquid chromatography detection of the present invention has a length of 100 mm, an inner diameter of 2.1 mm, and a particle size of 1.7 μm.

[0098] In some specific embodiments, the mobile phase A used in the liquid chromatography detection of the present invention is acetonitrile or methanol. In some preferred embodiments, the mobile phase A used in the liquid chromatography detection of the present invention is acetonitrile.

[0099] In some specific embodiments, the mobile phase B used in the liquid chromatography detection of the present invention is an aqueous formic acid solution, an aqueous acetic acid solution, an aqueous phosphoric acid solution or water. In some preferred embodiments, the mobile phase B used in the liquid chromatography detection of the present invention is an aqueous formic acid solution. In some more preferred embodiments, the mobile phase B used in the liquid chromatography detection of the present invention is an aqueous formic acid solution having a concentration of 0.2% by volume of formic acid.

[0100] In some specific embodiments, the liquid chromatography detection of the present invention adopts gradient elution. In other specific embodiments, the liquid chromatography detection of the present invention adopts isocratic elution, and the volume ratio of the mobile phase A to the mobile phase B is 15:85 to 50:50, preferably 20:80 to 40:60, even more preferably 25:75 to 35:65, and specifically can be 15:85, 17:83, 20:80, 23:77, 25:75, 27:73, 29:71, 35:65, 40:60, 45:55 or 50:50, etc.

[0101] In some specific embodiments, the mobile phase flow rate used in the liquid chromatography detection of the present invention is 0.20-0.40 mL / min, specifically 20 mL / min, 25 mL / min, 30 mL / min, 35 mL / min or 40 mL / min. In some preferred embodiments, the flow rate used in the liquid chromatography detection of the present invention is 0.25-0.35 mL / min.

[0102] In some specific embodiments, the chromatographic column temperature used in the ultra-high performance liquid chromatography detection of the present invention is 20-45° C., specifically 20° C., 25° C., 30° C., 35° C., 40° C. or 45° C. In some preferred embodiments, the chromatographic column temperature used in the ultra-high performance liquid chromatography detection of the present invention is 25-35° C.

[0103] In some specific embodiments, the ultra-high performance liquid chromatography detection of the present invention uses an ultraviolet detector, an evaporative light scattering detector, a differential refractive index detector or a charged aerosol detector. In some preferred embodiments, the ultra-high performance liquid chromatography detection of the present invention uses a charged aerosol detector.

[0104] In some specific embodiments, the conditions adopted for ultra-high performance liquid chromatography detection of the present invention are as follows: the chromatographic column filler is octadecylsilane bonded silica gel; the mobile phase A is acetonitrile or methanol, and the mobile phase B is formic acid aqueous solution, acetic acid aqueous solution, phosphoric acid aqueous solution or water, and gradient elution or isocratic elution is performed, the volume ratio of mobile phase A to mobile phase B is 15:85 to 50:50, and the flow rate is 0.20-0.40mL / min; the column temperature is 20-45°C; and an ultraviolet detector, an evaporative light scattering detector, a differential refractometer detector or an charged aerosol detector is used.

[0105] In some preferred embodiments, the conditions adopted for ultra-high performance liquid chromatography detection of the present invention are: the chromatographic column filler is octadecylsilane bonded silica gel; the mobile phase A is acetonitrile, the mobile phase B is a formic acid aqueous solution with a concentration of 0.2% by volume of formic acid, and isocratic elution is performed, the volume ratio of mobile phase A to mobile phase B is 29:71, and the flow rate is 0.25-0.35 mL / min; the column temperature is 25-35°C; and a charged aerosol detector is used.

[0106] In some specific embodiments, the present invention uses ultra-high performance liquid chromatography to detect the peak area of ​​sanguisorbaenoside I in the reference solution and the test solution, and calculates the content of sanguisorbaenoside I in the test sample using the external two-point logarithmic equation based on the injection volume and the logarithmic value of the peak area, so as to perform quality detection of the holly leaf sample.

[0107] In order to more clearly describe the technical solution of the present invention, the following is further described in conjunction with specific embodiments, but it cannot be used to limit the present invention. This is only a partial embodiment of the present invention. Unless otherwise specified, the instruments, reagents, materials, experimental animals, etc. used in the present invention can be obtained by conventional commercial means.

[0108] Example 1: Construction of a method for determining the content of medicinal materials in holly leaves

[0109] 1. Instruments, reagents and samples

[0110] Thermo Vanquish ultra-high performance liquid chromatograph; Thermo Vanquish charged aerosol detector (CAD); Chromeleam 7.2 SR4 Chameleon workstation; KQ-250E ultrasonic cleaning machine (Kunshan Ultrasonic Instrument Co., Ltd.); METTLER TOLEDO XP6 1 / 10000 balance (Mettler-Toledo (Shanghai) Instrument Co., Ltd.); ME204E / 02 electronic analytical balance (Mettler-Toledo Instrument (Shanghai) Co., Ltd.); KQ-250B ultrasonic cleaning machine (Kunshan Ultrasonic Instrument Co., Ltd.); pure water system (Sartorius); GKC114 temperature-controlled water bath (Nantong Huatai Experimental Instrument Co., Ltd.); AS165W centrifuge (Azov (Shanghai) Trading Co., Ltd.). Acetonitrile (chromatographic grade, Thermo Fisher); water is ultrapure water; formic acid (chromatographic grade, Aladdin); other reagents are of analytical grade.

[0111] Sanguisorba officinalis saponin I (No. ST0820120MG) was purchased from Shanghai Shidande Biotechnology Co., Ltd. for content determination, with a content of 98.0%, and no treatment was required before use. Holly leaf medicinal materials were provided by Jiangyin Tianjiang Pharmaceutical Co., Ltd.

[0112] 2. Preparation of reference solution

[0113] Take an appropriate amount of Sanguisorba officinalis saponin I reference substance, weigh it accurately, and add 70% methanol to make a solution containing 50 μg per 1 mL. Perform ultra-high performance liquid chromatography on it, and the results are shown in Figure 1 .

[0114] 3. Preparation of test solution

[0115] Take about 0.5g of the powder of this product, weigh it accurately, put it in a stoppered conical flask, accurately add 50mL of 70% methanol, stopper it, weigh it, and treat it with ultrasound (power 250W, frequency 40kHz) for 30 minutes. Let it cool, weigh it again, make up the lost weight with 70% methanol, shake it well, filter it, take 25mL of the filtrate, evaporate it to dryness, add 70% methanol to dissolve the residue, transfer it to a 10mL volumetric flask, add 70% methanol to the scale, shake it well, filter it, and take the filtrate.

[0116] 4. Determination of analytical methods

[0117] 4.1 Chromatographic conditions

[0118] Octadecylsilane bonded silica gel was used as filler (column length 100mm, inner diameter 2.1mm, particle size 1.7μm); acetonitrile-0.2% formic acid solution (29:71) was used as mobile phase; charged aerosol detector was used for detection. The theoretical plate number should be no less than 5000 based on the peak of sanguisorba officinalis saponin I. Accurately aspirate 0.5μL and 4.0μL of the reference solution and 3μL of the test solution, inject into the liquid chromatograph for determination. Calculate using the logarithmic equation of the external two-point method to obtain the value.

[0119] The results showed that the detection baseline was stable, the target components were well separated, and the detection time could be completed within 12 minutes.

[0120] 4.2 Preparation of test solution

[0121] (1) Investigation of extraction solvent

[0122] Conclusion: When methanol, 70% methanol, 50% methanol, 30% methanol and water were used as extraction solvents, it was found that the content of Sanguisorba officinalis saponin I was lower when water was used as the extraction solvent, while the contents obtained by extraction with 70% methanol and 50% methanol were higher. Considering that there is a solvent evaporation step in the operation, the extraction solvent was determined to be 70% methanol, which evaporates the solvent faster.

[0123] Investigation method: Take about 0.5g of this product, a total of 5 groups, 2 parallel portions in each group, accurately weigh, put in a stoppered conical flask, accurately add methanol, 70% methanol, 50% methanol, 30% methanol, and 50mL of water, plug it tightly, weigh the weight, ultrasonically treat (power 250W, frequency 40kHz) for 30 minutes, let it cool, weigh it again, make up the lost weight with the corresponding solvent, shake it well, filter it, take 25mL of the filtrate, evaporate it to dryness, add 70% methanol to dissolve the residue, transfer it to a 10mL volumetric flask, add 70% methanol to the scale, shake it well, filter it, take the filtrate, and get it. Accurately aspirate 3μL of each test solution, inject it into the liquid chromatograph, inject it according to the chromatographic conditions under "4.1", and calculate the content of Sanguisorba officinalis saponin I. The results are shown in Table 1. Figure 2 .

[0124] Table 1 Comparison of different extraction solvents

[0125]

[0126] (2) Investigation of extraction methods

[0127] Conclusion: There is no significant difference in the content of sanguisorbaenoside I when ultrasonic treatment, heating reflux and shaking extraction are used. Considering the simplicity of ultrasonic treatment, ultrasonic treatment was chosen.

[0128] Investigation method: Take about 0.5g of this product, a total of 3 groups, 2 parallel parts in each group, accurately weigh, put in a stoppered conical bottle, accurately add 50mL of 70% methanol, seal, weigh, ultrasonically treat (power 250W, frequency 40kHz), heat reflux, shake and extract for 30 minutes, let cool, weigh again, make up the lost weight with 70% methanol, shake well, filter, take 25mL of the filtrate, evaporate to dryness, add 70% methanol to dissolve the residue, transfer to a 10mL volumetric flask, add 70% methanol to the scale, shake well, filter, take the filtrate, and get it. Accurately aspirate 3μL of each test solution, inject it into the liquid chromatograph, inject according to the chromatographic conditions under "4.1", and calculate the content of Sanguisorba officinalis saponin I. The results are shown in Table 2. Figure 3 .

[0129] Table 2 Comparison of extraction methods

[0130]

[0131] (3) Investigation of extraction solvent volume

[0132] Conclusion: When the extraction volume is 20mL, 50mL, and 100mL, the content of Sanguisorba officinalis saponin I obtained is not much different, indicating that the extraction is relatively sufficient when the extraction solvent is 20mL. Considering the differences between different batches of samples, in order to ensure sufficient extraction, the amount of solvent added is 50mL.

[0133] Investigation method: Take about 0.5g of this product, a total of 3 groups, 2 parallel parts in each group, accurately weigh, put in a stoppered conical bottle, accurately add 70% methanol 20mL, 50mL, 100mL respectively, stopper, weigh, ultrasonic treatment (power 250W, frequency 40kHz) for 30 minutes, let cool, weigh again, make up the lost weight with methanol, shake well, filter, take 20mL, 50mL, 100mL of the filtrate respectively, evaporate to dryness, add 70% methanol to dissolve the residue, transfer to a 10mL volumetric flask, add 70% methanol to the scale, shake well, filter, take the filtrate, and get it. Accurately aspirate 3μL of each test solution, inject into the liquid chromatograph, inject according to the chromatographic conditions under "4.1", and calculate the content of Sanguisorba officinalis saponin I. The results are shown in Table 3. Figure 4 .

[0134] Table 3 Comparison of extraction volumes

[0135]

[0136] (4) Investigation of extraction time

[0137] Conclusion: The content of sanguisorbaenoside I obtained at different ultrasonic treatment times is not much different, indicating that the extraction is relatively sufficient when the extraction time is 15 minutes. Considering the differences between different batches of samples, the extraction time is 30 minutes to ensure sufficient extraction.

[0138] Investigation method: Take about 0.5g of this product, a total of 3 groups, 2 parallel parts in each group, accurately weigh, put in a stoppered conical bottle, accurately add 50mL of 70% methanol, seal, weigh, ultrasonically treat (power 250W, frequency 40kHz) for 15min, 30min, and 45min respectively, let cool, weigh again, make up the lost weight with methanol, shake well, filter, take 25mL of the filtrate, evaporate to dryness, add 70% methanol to dissolve the residue, transfer to a 10mL volumetric flask, add 70% methanol to the scale, shake well, filter, take the filtrate, and get it. Accurately aspirate 3μL of each test solution, inject into the liquid chromatograph, inject according to the chromatographic conditions under "4.1", and calculate the content of Sanguisorba officinalis saponin I. The results are shown in Table 4. Figure 5 .

[0139] Table 4 Comparison of extraction time

[0140]

[0141] The final preparation method of the test solution was determined as follows:

[0142] Take about 0.5g of the powder of this product, weigh it accurately, put it in a stoppered conical flask, accurately add 50mL of 70% methanol, stopper it, weigh it, and treat it with ultrasound (power 250W, frequency 40kHz) for 30 minutes. Let it cool, weigh it again, make up the lost weight with methanol, shake it well, filter it, take 25mL of the filtrate, evaporate it to dryness, add 70% methanol to dissolve the residue, transfer it to a 10mL volumetric flask, add 70% methanol to the scale, shake it well, filter it, and take the filtrate.

[0143] (5) Testing of different batches

[0144] Take 10 different batches of samples, prepare the samples according to the preparation method of the test solution in "4.2", and analyze them according to the chromatographic conditions in "4.1". The specific results are as follows:

[0145] Table 5 Contents of Sanguisorba officinalis saponin I in different batches of holly leaves

[0146]

[0147] As can be seen from the above table, the content of sanguisorbaenoside I in the above batches of holly leaf medicinal materials ranges from 0.07% to 0.21%, with a large difference, which may be affected by factors such as origin and harvesting. This shows that this indicator has a certain reference significance for the quality evaluation of holly leaf.

[0148] Example 2: Methodological Validation of the Content Assay Construction Method

[0149] 1. Linear Relationship

[0150] The results showed that when the injection amount of Sanguisorba officinalis saponin I was in the range of 0.02972-0.59447 μg, its Ln value showed a good linear relationship with the Ln value of the peak area.

[0151] Accurately draw 0.3, 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 5.0, 6.0 μL of the reference solution of Sanguisorba officinalis saponin I (concentration of 99.078 μg / mL), inject into liquid chromatograph, inject according to the chromatographic conditions under "4.1" of Example 1, take the Ln value of the peak area as the ordinate, take the Ln value of the injection amount as the abscissa, draw the standard curve, and obtain the regression equation: Y=0.8706x+1.958, R=0.9993. The results are shown in Table 6 and the spectrum is shown in Figure 6 .

[0152] Table 6 Relationship between the peak area integral value of the reference substance and the injection volume

[0153]

[0154] 2. Precision test

[0155] 2.1 Instrument precision test

[0156] Results: The peak area RSD was 2.50%, and the instrument precision test was good.

[0157] Accurately pipette 3 μL of the test solution of holly leaf medicinal material, inject it into the liquid chromatograph, and inject according to the chromatographic conditions under "4.1" of Example 1, inject 6 times continuously, record the measured value of the peak area of ​​sanguisorba officinalis saponin I, calculate the relative standard deviation, and the results are shown in Table 7.

[0158] Table 7 Instrument precision test

[0159]

[0160] 2.2 Repeatability test

[0161] Results: The peak area RSD was 1.97%, and the repeatability test was good.

[0162] About 0.5 g of samples from the same batch were taken, accurately weighed, and 6 parallel portions were prepared. The samples were prepared according to the preparation method of the test solution under "4.2" of Example 1. The samples were injected and analyzed according to the chromatographic conditions under "4.1" of Example 1. The peak area of ​​sanguisorbaside I was measured, and the content and RSD value of sanguisorbaside I were calculated. The results are shown in Table 8.

[0163] Table 8 Repeatability test of the content of holly leaf medicinal material samples

[0164]

[0165] 2.3 Intermediate precision

[0166] Results: The RSD of the content of Sanguisorba officinalis saponin I was 1.55%, and the intermediate precision test was good.

[0167] Three samples from the same batch were taken, and different experimenters prepared the samples according to the preparation method of the test solution under "4.2" of Example 1. According to the chromatographic conditions under "4.1" of Example 1, 3 μL was injected on the same instrument at different times, the peak area value of Sanguisorba officinalis saponin I was determined, and its content and RSD were calculated. The results are shown in Table 9.

[0168] Table 9 Intermediate precision test

[0169]

[0170] 3. Accuracy test

[0171] Results: The average recovery rate of Sanguisorba officinalis saponin I was 101.09% and the RSD was 1.99%, indicating a good accuracy test.

[0172] Take 0.25 g of a sample with a known content (Sanguisorba officinalis saponin I content 0.199%), and make six parallel portions, accurately weigh them, and add the reference solution corresponding to the Sanguisorba officinalis saponin I contained in 0.25 g of the sample to each portion, and prepare the sample recovery test solution according to the preparation method of the test solution under "4.2" of Example 1. The sample was injected according to the chromatographic conditions under "4.1" of Example 1, and 3 μL was injected respectively. The recovery rate and RSD were calculated using the following formula. The results are shown in Table 10.

[0173]

[0174] Table 10 Accuracy experiment

[0175]

[0176] 4. Specificity test

[0177] Conclusion: The results show that the blank solvent has no interference with the determination of Sanguisorba officinalis saponin I, and the method has strong specificity.

[0178] Take blank solvent, Sanguisorba officinalis saponin I reference substance solution, and Ilex oleifera medicinal material test solution, and inject according to the chromatographic conditions under "4.1" of Example 1. The results are shown in Figure 7 .

[0179] 5. Durability test

[0180] 5.1 Stability test

[0181] Results: The test solution had good stability within 24 hours (RSD%<2.0%).

[0182] Take 1 sample, prepare the test solution according to the preparation method of the test solution under "4.2" of Example 1, inject 3 μL at 0, 2, 4, 6, 10, 12, 14, 16, 18, 20, and 24 hours, measure the peak area value, and calculate its RSD value. The results are shown in Table 11.

[0183] Table 11 Stability test results

[0184]

[0185] 5.2 Investigation of different flow rates

[0186] Results: There was no difference in the measurement results between the flow rates of 0.25 mL / min and 0.35 mL / min, and the durability was good.

[0187] Take one sample and prepare the test solution according to the preparation method of the test solution under "4.2" of Example 1, and investigate the effects of three flow rates of 0.25mL / min, 0.30mL / min, and 0.35mL / min on the chromatographic peak separation and content results. The results are shown in Table 12. Figure 8 .

[0188] Table 12 Investigation of different flow rates

[0189]

[0190] 5.3 Column temperature investigation

[0191] Results: When the column temperature was between 25℃ and 35℃, there was no significant difference in the measurement results, and the durability was good.

[0192] Take 1 sample and prepare the test solution according to the preparation method of the test solution under "4.2" of Example 1. Test the three temperatures of 25°C, 30°C and 35°C. The results are shown in Table 13. Fig. 9 .

[0193] Table 13 Investigation of different column temperatures

[0194]

[0195] 5.4 Chromatographic column investigation

[0196] Results: The separation effects of three different types of octadecylsilane bonded silica gel chromatographic columns were good and the retention times were moderate, indicating that the chromatographic columns had little effect on the determination results of the samples.

[0197] Take one sample and prepare a test solution according to the preparation method of the test solution under "4.2" of Example 1. Column 1: BEH C18 (2.1 mm × 100 mm, 1.7 μm), column 2: BEH Shield RP18 (2.1 mm × 100 mm, 1.7 μm), column 3: Eclipse Plus RRHD C18 (Agilent, 2.1 × 100 mm, 1.8 μm) were used for analysis. The results are shown in Table 14. Fig.10 .

[0198] Table 14 Comparison of different chromatographic columns

[0199]

[0200] Example 3: Specificity test for determination of the content of Sanguisorba officinalis saponin I in Holly Leaf Pieces

[0201] Conclusion: The results show that the solvent has no interference with the determination of sanguisorbaenoside I in holly leaf slices. This method has strong specificity and is suitable for the content determination of holly leaf slices.

[0202] Take about 0.5g of holly leaf slices, prepare slice solution according to the preparation method of the test solution under "4.2" of Example 1, then take blank solvent, and inject according to the chromatographic conditions under "4.1" of Example 1. The results are shown in Fig.11.

[0203] Example 4: Specificity test for determination of the content of Sanguisorba officinalis saponin I in standard decoction of holly leaves

[0204] Conclusion: The results show that the solvent has no interference with the determination of sanguisorbaenoside I in the standard decoction of holly leaves. This method has strong specificity and is suitable for the content determination of the standard decoction of holly leaves.

[0205] Take 0.2g of standard decoction of holly leaves, prepare a decoction solution according to the preparation method of the test solution under "4.2" of Example 1, and then take a blank solvent, and inject it according to the chromatographic conditions under "4.1" of Example 1. The results are shown in Fig.12 .

[0206] Example 5: Specificity test for determination of the content of Sanguisorba officinalis saponin I in Holly Leaf Formula Granules

[0207] Conclusion: The results show that the excipients have no interference with the determination of sanguisorba officinalis saponin I in holly leaf formula granules. This method has strong specificity and is suitable for the content determination of holly leaf formula granules.

[0208] The auxiliary materials added to the holly leaf formula granules are maltodextrin, silicon dioxide and magnesium stearate. The holly leaf formula granules and the negative sample lacking holly leaves are taken to prepare the formula granule solution and the negative solution respectively according to the preparation method of the test solution under "4.2" of Example 1, and the samples are injected according to the chromatographic conditions under "4.1" of Example 1. The results are shown in FIG. Fig.13 .

[0209] The above-mentioned embodiments only express several implementation methods of the present invention, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the present invention. It should be pointed out that, for a person of ordinary skill in the art, several variations and improvements can be made without departing from the concept of the present invention, and these all belong to the protection scope of the present invention. Therefore, the protection scope of the present invention's patent shall be based on the claims.

Claims

1. A method for detecting the quality of holly leaf samples, comprising the following steps: preparation of a reference solution, preparation of a test solution, ultra-high performance liquid chromatography detection and data analysis, in, The data analysis includes calculating the content of sanguisorba officinalis saponin I in the holly leaf sample; The holly leaf sample is selected from one or more of the medicinal materials, decoction pieces, extracts, standard decoctions and formula granules of holly leaves; The preparation of the test solution comprises the following steps: taking holly leaf sample powder, accurately weighing, placing in a container, accurately adding an extraction solvent, sealing, weighing, cooling after extraction, weighing again, supplementing the lost weight with the extraction solvent, shaking, filtering, taking one-half volume of the filtrate, evaporating to dryness, adding the extraction solvent to the residue to redissolve, transferring to a quantitative container, adding the extraction solvent to the fixed volume, shaking, filtering, taking the filtrate, and obtaining; wherein the extraction solvent is a methanol aqueous solution; the mass volume ratio of the holly leaf sample powder to the extraction solvent is 1g:(15~800mL); The conditions adopted by the ultra-high performance liquid chromatography detection include: the chromatographic column filler is octadecylsilane bonded silica gel; the mobile phase A is acetonitrile; the mobile phase B is a formic acid aqueous solution with a concentration of 0.2% by volume of formic acid; the mobile phase A and the mobile phase B are used for isocratic elution, and the volume ratio of the mobile phase A to the mobile phase B is 15:85 to 29:71; and a charged aerosol detector is used.

2. The quality inspection method according to claim 1, It is characterized in that The conditions adopted by the ultra-high performance liquid chromatography detection also include: a flow rate of 0.20-0.40 mL / min; and a column temperature of 20-45°C.

3. The quality inspection method according to claim 1, It is characterized in that The concentration of the methanol aqueous solution is greater than or equal to 30% by volume of methanol.

4. The quality inspection method according to claim 1, It is characterized in that The extraction is performed by ultrasound, heating reflux or shaking, and the extraction time is 5-60 minutes.

5. The quality inspection method according to claim 1, It is characterized in that The preparation of the reference solution comprises the following steps: taking a reference substance of Sanguisorba officinalis saponin I, accurately weighing it, adding a solvent, and mixing it until it is dissolved and clear; wherein the solvent is an alcohol or an alcohol aqueous solution.

6. The quality inspection method according to claim 5, It is characterized in that The solvent is methanol or a methanol aqueous solution.

7. The quality inspection method according to claim 6, It is characterized in that The concentration of the methanol aqueous solution is greater than or equal to 30% by volume of methanol.

8. Use of the quality detection method according to any one of claims 1 to 7 in the quality detection of holly leaf samples.